Familial and Hereditary Forms of Primary Hyperparathyroidism

被引:24
作者
Cetani, F. [1 ]
Saponaro, F. [2 ]
Borsari, S. [2 ]
Marcocci, C. [2 ]
机构
[1] Univ Hosp Pisa, Endocrine Unit 2, Univ Pisa, Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Endocrine Unit 2, Pisa, Italy
来源
PARATHYROID DISORDERS: FOCUSING ON UNMET NEEDS | 2019年 / 51卷
关键词
ENDOCRINE NEOPLASIA SYNDROME; CALCIUM-SENSING RECEPTOR; MUTATIONS; GUIDELINES; MANAGEMENT; DISORDERS;
D O I
10.1159/000491037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individuals with a familial predisposition to the development of parathyroid tumors constitute a small minority of all patients with primary hyperparathyroidism (PHPT). These familial syndromes exhibit Mendelian inheritance patterns and the main causative genes in most families have been identified. They include multiple endocrine neoplasia (MEN; types 1, 2A, and 4), hyperparathyroidism- jaw tumor (HPT-JT) syndrome, familial isolated hyperparathyroidism, familial hypocalciuric hypercalcemia (FHH), and neonatal severe PHPT. Each MEN type is associated with the various combinations of specific tumors. MEN1 is characterized by the occurrence of parathyroid, enteropancreatic, and pituitary tumors; MEN2A is characterized by medullary thyroid carcinoma and pheochromocytoma, and MEN4 is characterized by a pathological spectrum similar to that of MEN1 in association with tumors of the adrenal, kidney, and reproductive organs. HPT-JT is characterized by PHPT, ossifying fibromas of maxillary bones, kidney disease, and uterine neoplasias. The prompt diagnosis of these diseases is of great importance for planning appropriate surveillance of the mutant carriers and correct surgical management. The search for mutation is also useful for the identification of the family members who do not carry the mutation and can avoid unnecessary biochemical and instrumental evaluations. Surgery remains the treatment of choice in all familial forms except FHH. (c) 2019 S. Karger AG, Basel
引用
收藏
页码:40 / 51
页数:12
相关论文
共 26 条
[1]   MEN4 and CDKN1B mutations: the latest of the MEN syndromes [J].
Alrezk, Rami ;
Hannah-Shmouni, Fady ;
Stratakis, Constantine A. .
ENDOCRINE-RELATED CANCER, 2017, 24 (10) :T195-T208
[2]   Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome [J].
Bradley, KJ ;
Hobbs, MR ;
Buley, ID ;
Carpten, JD ;
Cavaco, BM ;
Fares, JE ;
Laidler, P ;
Manek, S ;
Robbins, CM ;
Salti, IS ;
Thompson, NW ;
Jackson, CE ;
Thakker, RV .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) :18-26
[3]   Frequent Large Germline HRPT2 Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism [J].
Bricaire, Leopoldine ;
Odou, Marie-Francoise ;
Cardot-Bauters, Catherine ;
Delemer, Brigitte ;
North, Marie-Odile ;
Salenave, Sylvie ;
Vezzosi, Delphine ;
Kuhn, Jean-Marc ;
Murat, Arnaud ;
Caron, Philippe ;
Sadoul, Jean-Louis ;
Silve, Caroline ;
Chanson, Philippe ;
Barlier, Anne ;
Clauser, Eric ;
Porchet, Nicole ;
Groussin, Lionel .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) :E403-E408
[4]   Parathyroid carcinoma: a clinical and genetic perspective [J].
Cetani, Filomena ;
Pardi, Elena ;
Marcocci, Claudio .
MINERVA ENDOCRINOLOGICA, 2018, 43 (02) :144-155
[5]   Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism [J].
Frank-Raue, Karin ;
Leidig-Bruckner, Gudrun ;
Haag, Christine ;
Schulze, Egbert ;
Lorenz, Angela ;
Schmitz-Winnenthal, Hubertus ;
Raue, Friedhelm .
CLINICAL ENDOCRINOLOGY, 2011, 75 (01) :50-55
[6]   Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database [J].
Giusti, Francesca ;
Cianferotti, Luisella ;
Boaretto, Francesca ;
Cetani, Filomena ;
Cioppi, Federica ;
Colao, Annamaria ;
Davi, Maria Vittoria ;
Faggiano, Antongiulio ;
Fanciulli, Giuseppe ;
Ferolla, Piero ;
Ferone, Diego ;
Fossi, Caterina ;
Giudici, Francesco ;
Gronchi, Giorgio ;
Loli, Paola ;
Mantero, Franco ;
Marcocci, Claudio ;
Marini, Francesca ;
Masi, Laura ;
Opocher, Giuseppe ;
Beck-Peccoz, Paolo ;
Persani, Luca ;
Scillitani, Alfredo ;
Sciortino, Giovanna ;
Spada, Anna ;
Tomassetti, Paola ;
Tonelli, Francesco ;
Brandi, Maria Luisa .
ENDOCRINE, 2017, 58 (02) :349-359
[7]   Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) [J].
Giusti, Francesca ;
Cianferotti, Luisella ;
Gronchi, Giorgio ;
Cioppi, Federica ;
Masi, Laura ;
Faggiano, Antongiulio ;
Colao, Annamaria ;
Ferolla, Piero ;
Brandi, Maria Luisa .
ENDOCRINE, 2016, 52 (03) :495-506
[8]   GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism [J].
Guan, Bin ;
Welch, James M. ;
Sapp, Julie C. ;
Ling, Hua ;
Li, Yulong ;
Johnston, Jennifer J. ;
Kebebew, Electron ;
Biesecker, Leslie G. ;
Simonds, William F. ;
Marx, Stephen J. ;
Agarwal, Sunita K. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 99 (05) :1034-1044
[9]   Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis [J].
Hannan, Fadil M. ;
Babinsky, Valerie N. ;
Thakker, Rajesh V. .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2016, 57 (03) :R127-R142
[10]   The same pocket in menin binds both MLL and JUND but has opposite effects on transcription [J].
Huang, Jing ;
Gurung, Buddha ;
Wan, Bingbing ;
Matkar, Smita ;
Veniaminova, Natalia A. ;
Wan, Ke ;
Merchant, Juanita L. ;
Hua, Xianxin ;
Lei, Ming .
NATURE, 2012, 482 (7386) :542-U141